The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
LCRF Pilot Grant Program
The LCRF pilot grant program funds innovative projects across the full spectrum of basic, translational, clinical, epidemiological, health services, early detection, disparities, and social determinants of health research, focused on one or more of the following topics:
- Lung cancer biology
- Prevention and screening for early detection
- Identification of new biomarkers
- Development of more effective and less toxic therapies including but not limited to targeted and immune-therapies
- Genetic and gene-environment interactions
- Interactions and contributions of multiple factors (e.g. smoking, genetics, environment, societal factors) to disparities in lung cancer outcomes
- Mechanisms of sensitivity and resistance to lung cancer therapies
- Bioengineering approaches to understanding and/or treating lung cancer (i.e., theranostics, biomaterials, nanotechnology, controlled-drug release, and gene-therapy)
- Supportive measures for people with lung cancer and their families
These awards provide a maximum of $150,000 in funding over a period of two years to early- and mid-career investigators. For full details, eligibility criteria, and application instructions, please refer to the request for proposals.
Deadline for LOI: April 30, 2022
Areas of Interest
Investigators must be affiliated with a non-profit academic or research institution and must be post-doctoral researchers, clinical fellows, or early-career and mid-career investigators with less than ten years’ experience since their initial faculty appointment. Applicants from US-based and international institutions are eligible to apply and may hold any residency/citizenship status.
- The maximum award amount is $150,000 for a period of two years (disbursed at $75,000 per year).